Clinical Trials Browser

Phase 2/3 × Completed × apatinib × Clear all

NCT02711007 2018-04-23

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Phase 2/3 Completed

Neoplasm Metastasis, Osteosarcoma

NCT00970138 2011-07-12

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms